-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Black Diamond Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2018 to Q3 2024.
- Black Diamond Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$15.6M, a 32.4% increase year-over-year.
- Black Diamond Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$73.1M, a 13.1% increase year-over-year.
- Black Diamond Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$82.4M, a 9.57% increase from 2022.
- Black Diamond Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$91.2M, a 27.4% increase from 2021.
- Black Diamond Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$126M, a 86.7% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)